The Elusive Magic Bullet: The Search for the Perfect Drug
Description:
In his exciting new book, John Mann, author of the highly successful Murder, Magic and Medicine, reveals the history of the drugs that are so commonplace today in the treatment of disease. While we can now treat so many of these illnesses, the side-effects caused by many of these treatmentscan be severe, and even more worrying -- the bacteria are now becoming more resistant to the drugs (the so-called 'superbugs'). Scientists are also faced with a massive challenge in developing drugs that can effectively treat HIV, ebola, and many forms of cancer, but without the terribleside-effects of such treatments as chemotherapy or AZT -- this is the quest for the `magic bullet.'The book starts with a history of drug development, introducing us to some of the fascinating characters whose work so influenced the search for these drugs. Leading up to the present day, and the exciting advances being made within molecular biology, the book provides a lively, and fascinatingintroduction for non-scientists to one of the most exciting fields of activity within modern medicine.
Best prices to buy, sell, or rent ISBN 9780198500933
Frequently Asked Questions about The Elusive Magic Bullet: The Search for the Perfect Drug
The price for the book starts from $7.12 on Amazon and is available from 8 sellers at the moment.
If you’re interested in selling back the The Elusive Magic Bullet: The Search for the Perfect Drug book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the The Elusive Magic Bullet: The Search for the Perfect Drug book, the best buyback offer comes from and is $ for the book in good condition.
The The Elusive Magic Bullet: The Search for the Perfect Drug book is in very low demand now as the rank for the book is 10,857,218 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.